(Q36541242)

14 August 2017

1 reference

title

Hypoxia in head and neck cancer (English)

1 reference

14 August 2017

0 references

3

West CM

1 reference

14 August 2017

Isa AY

1

1 reference

14 August 2017

Ward TH

series ordinal

2

1 reference

14 August 2017

Slevin NJ

series ordinal

4

1 reference

14 August 2017

Homer JJ

series ordinal

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

19 July 2006

1 reference

British Journal of Radiology

14 August 2017

published in

1 reference

14 August 2017

volume

79

1 reference

14 August 2017

issue

946

1 reference

14 August 2017

page(s)

791-798

1 reference

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxia and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

The histological structure of some human lung cancers and the possible implications for radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Angiogenesis: how a tumor adapts to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

21 January 2018

Measuring Tumor Hypoxia

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Differentiation-associated staining with anti-pimonidazole antibodies in head and neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Expression of hexokinase II and Glut-1 in untreated human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Prognostic significance of p53, Ki-67, VEGF and Glut-1 in resected stage I adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Microregional expression of glucose transporter-1 and oxygenation status: lack of correlation in locally advanced cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Osteopontin overproduced by tumor cells acts as a potent angiogenic factor contributing to tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha).

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Influence of oxygen concentration and pH on expression of hypoxia induced genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

ARCON: a novel biology-based approach in radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

ARCON: experience in 215 patients with advanced head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Hypoxia as a target for combined modality treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Pharyngocutaneous fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1259%2FBJR%2F17904358

21 January 2018

Identifiers

DOI

10.1259/BJR/17904358

1 reference

14 August 2017

1 reference